Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Zomedica s Fourth Quarter and Full-Year 2023 Earnings Release and Business Update Call.
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Zomedica s Third Quarter 2023 Earnings Release and Business Update Call.
First-of-its-Kind Study in HIV Compares IbalizumabClinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA®CohortData Presented at ACTHIV™Conference Highlight Improved Clinical Outcomes of Ibalizumab for Heavily Treatment-ExperiencedPeople with HIV
Theratechnologies' (THTX) Trogarzo Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Theratechnologies' Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.